Solvonis Therapeutics plc

Solvonis Therapeutics is a clinical-stage biotechnology company developing psychedelics therapeutics for addiction, post-traumatic stress disorder (PTSD) and depression. We are building an alcohol use disorder (AUD) franchise across the UK, Europe and the U.S., with a de novo engine of proprietary new medicines behind it.